Evidence map›Paper›PMID 38361169›Full record

Trial reportAIDS and behavior2024

Behavioral Modeling and its Association with PrEP and ART Use in Ugandan HIV-Serodifferent Couples.

Liying Wang, Timothy R Muwonge, Jane M Simoni, Florence Nambi, Lylianne Nakabugo, Joseph Kibuuka, Dorothy Thomas, Ingrid T Katz, Erika Feutz, Katherine K Thomas and 6 more

Open access · hybridAbstract readObservational StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in AIDS and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 2 countries.

Liying WangDepartment of Psychology, University of Washington, Seattle, WA, USA.
Timothy R MuwongeInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Jane M SimoniDepartment of Psychology, University of Washington, Seattle, WA, USA.
Florence NambiInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Lylianne NakabugoInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Joseph KibuukaInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Dorothy ThomasDepartment of Global Health, University of Washington, Seattle, WA, USA.
Ingrid T KatzDepartment of Global Health and Social Medicine, Harvard Medical School, 25 Shattuck St, Boston, Massachusetts, USA.
Erika FeutzDepartment of Global Health, University of Washington, Seattle, WA, USA.
Katherine K ThomasDepartment of Global Health, University of Washington, Seattle, WA, USA.
Norma C WareDepartment of Global Health and Social Medicine, Harvard Medical School, 25 Shattuck St, Boston, Massachusetts, USA.
Monique A WyattDepartment of Global Health and Social Medicine, Harvard Medical School, 25 Shattuck St, Boston, Massachusetts, USA.
Herbert KadamaMinistry of Health, Box 7272, Kampala, Uganda.
Andrew MujugiraInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Renee HeffronDepartment of Global Health, University of Washington, Seattle, WA, USA. rheffron@uabmc.edu.
Partners PrEP Program Study Team
University of Washington · USInfectious Diseases Institute · UGMakerere University · UGBrigham and Women's Hospital · USHarvard Global Health Institute · USLemuel Shattuck Hospital · USMinistry of Health · UGNational Institutes of Health · USUniversity of Washington Medical Center · US

Funding

Integrated PrEP and ART delivered in Ugandan public health clinics to improve HIV and ART outcomes for HIV serodiscordant couplesR01MH110296 · NIMH · UNIVERSITY OF WASHINGTON · PI HEFFRON, RENEE A. · 2017 to 2021
$3.2M
Mentoring and research to prepare oral PrEP delivery platforms for novel HIVprevention productsK24MH123371 · NIMH · UNIVERSITY OF WASHINGTON · PI HEFFRON, RENEE A. · 2021 to 2025
$749k
NIMH NIH HHS K24 MH123371NIMH NIH HHS K24MH123371NIMH NIH HHS R01 MH110296NIMH NIH HHS R01MH110296
6 · The paper itself

Abstract

Integrating Pre-Exposure Prophylaxis (PrEP) delivery into Antiretroviral Therapy (ART) programs bridges the Human Immunodeficiency Virus (HIV) prevention gap for HIV-serodifferent couples prior to the partner living with HIV achieving viral suppression. Behavioral modeling is one mechanism that could explain health-related behavior among couples, including those using antiretroviral medications, but few tools exist to measure the extent to which behavior is modeled. Using a longitudinal observational design nested within a cluster randomized trial, this study examined the factor structure and assessed the internal consistency of a novel 24-item, four-point Likert-type scale to measure behavioral modeling and the association of behavioral modeling with medication-taking behaviors among heterosexual, cis-gender HIV-serodifferent couples. In 149 couples enrolled for research, a five-factor model provided the best statistical and conceptual fit, including attention to partner behavior, collective action, role modeling, motivation, and relationship quality. Behavioral modeling was associated with medication-taking behaviors among members of serodifferent couples. Partner modeling of ART/PrEP taking could be an important target for assessment and intervention in HIV prevention programs for HIV serodifferent couples.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisSexual PartnersAdultAnti-HIV AgentsDrug MonitoringFemaleHumansLongitudinal StudiesMaleMedication AdherenceSexual BehaviorUgandaAnti-HIV AgentsBehavioral modeling measureHIVMedication adherenceObservational learningSero-different couple

Identifiers

PMID38361169
PMCPMC11069469
OpenAlexW4392782952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.